Europe Dna Diagnostics Market Size & Outlook, 2024-2030
Europe dna diagnostics market, 2018-2030 (US$M)
Europe dna diagnostics market highlights
- The Europe dna diagnostics market generated a revenue of USD 2,577.5 million in 2023.
- The market is expected to grow at a CAGR of 3.9% from 2024 to 2030.
- In terms of segment, pcr-based diagnostics was the largest revenue generating technology in 2023.
- NGS DNA Diagnosis is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 2,577.5 million |
| Market revenue in 2030 | USD 3,366.3 million |
| Growth rate | 3.9% (CAGR from 2023 to 2030) |
| Largest segment | Pcr-based diagnostics |
| Fastest growing segment | NGS DNA Diagnosis |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | PCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics, Microarrays-based Diagnostics |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Hologic Inc, Siemens Healthineers AG ADR, Roche, Qiagen NV, Agilent Technologies Inc |
Other key industry trends
- In terms of revenue, Europe region accounted for 24.2% of the global dna diagnostics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,123.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
DNA Diagnostics Market Scope
DNA Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe dna diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna diagnostics market will help companies and investors design strategic landscapes.
Pcr-based diagnostics was the largest segment with a revenue share of 49.76% in 2024. Horizon Databook has segmented the Europe dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays-based diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
Europe is expected to account for a considerable revenue share of the DNA diagnostics market due to the presence of developed economies, such as Germany, Spain, the UK, France, and Italy. These countries have advanced infrastructure, which is anticipated to significantly boost clinical research prospects in the region.
Moreover, the growing incidence of genetic and chronic diseases, such as cancer, cardiovascular diseases, and infectious diseases, is predicted to drive the demand for DNA diagnostics. For instance, Neuroblastoma predominantly affects toddlers and young children, with around 1,500 new cases reported annually in the EU.
This malignant tumor targets the peripheral nervous system, with around 50% of patients classified as high-risk cases. Recurrences are common, and conventional treatments often prove ineffective for young patients.
Liquid biopsies are a promising diagnostic tool that can help monitor treatment efficacy and prediction of tumor recurrence on time. Leading European research institutions in pediatric oncology, coordinated by the European Society for Pediatric Oncology (SIOPE) and guided by the scientific expertise of the Princess Máxima Center for Pediatric Oncology and St. Anna Children’s Cancer Research Institute, are spearheading efforts to test & implement this innovative approach. The initiative, funded through a 5-year Horizon Europe project, aims to revolutionize the field.
Reasons to subscribe to Europe dna diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe dna diagnostics market databook
-
Our clientele includes a mix of dna diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe dna diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe dna diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe dna diagnostics market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
